Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by WarrantOfficeron Oct 26, 2022 7:51am
153 Views
Post# 35048966

RE:RE:RE:RE:Million Dollar Molecule

RE:RE:RE:RE:Million Dollar Moleculebiggdogg: 22 Mar 2021 Voyageur PR states: AVL recently completed construction in January 2021, of its modern and state of the art Good Manufacturing Practice ("GMP") pharmaceutical manufacturing facility. AVL received its Drug Establishment Licence (DEL) and have passed the inspection and are in full compliance for manufacturing, testing, distribution, importing API and labelling of powders, solutions, suspensions, pastes, ointments. Voyageur is excited to work with AVL and to continue to move Voyageur towards cash flow and full integration of its barium radiographic product lines and barium quarry.

Businesses where permitted to open back up in the beginning of 2021 in Alberta. I am not positive, but I am willing to state that AVL was not closed as it supplied much needed pharamceuticals to the live stock industry to keep everyone fed during the pandemic. There could have been some supply chain issues, but none where reported. 

IMO, it has been much to long to get one product fully around the bases (18 months). Now an additional product line, that will require finacing. If they apply for and receive government money for the process, great. The longer the wait, the greater the chance of another entitiy filling the gap. That's capitalism and big Pharma has much deeper pockets than our Voyageur. Speed is of the essence. 

.


 



<< Previous
Bullboard Posts
Next >>